NDTV Profit

Ajanta Pharma Gets USFDA Observation For Paithan Facility

Drug firm Ajanta Pharma on Thursday said the US health regulator has issued one observation for its Paithan facility in Aurangabad after the inspection.
EMAIL
COMMENTS
Ajanta Pharma Gets USFDA Observation For Paithan Facility
New Delhi: Drug firm Ajanta Pharma on Thursday said the US health regulator has issued one observation for its Paithan facility in Aurangabad after the inspection.

"This is to inform that our Paithan facility was recently inspected by the US FDA and we are issued one procedural related 483," Ajanta Pharma said in a BSE filing.

It further said: "We are in process of responding to the same within the stipulated time prescribed by US FDA."

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)

For latest news on Business & Budget 2017, like us on Facebook and follow us on Twitter.
ALSO READ Kotak Bank Launches 811 'Zero Balance, Zero Charge' Account. Details Here

Advertisement

Advertisement

GAINERS / LOSERS

Advertisement